A unique training with which the pharmacist will be able to specialize in Risk Situations Prevention Measurements and Infectious Diseases Therapy, under the guidance of professionals with years of experience in the sector"

This program offers the student the possibility of deepening and updating knowledge, using the latest educational technology. It offers a global vision of Risk Situations Prevention Measurements and Infectious Diseases Therapy, while focusing on the most important and innovative aspects.

This program arises as a response to an important need in the field of Infectious Diseases. Today, this need responds, among other things, to the emergence of certain diseases that are unknown or have little practice (zika, chikungunya, hemorrhagic fevers, among others), and with others that have fallen into oblivion or are unknown to less experienced pharmacists such as diphtheria, measles, pertussis (whooping cough), or flaccid paralysis associated with poliovirus vaccines.

At the therapeutic level, the emergence of resistance (BLEES, MRSA, carbapenem-resistant enterobacteria, etc.), often caused by the unwise and irrational use of drugs, creates problems for the clinician when it comes to initial empirical treatment in certain situations.

On the other hand, parents who refuse vaccines, children from low-income backgrounds, infections in transplant recipients, children with devices, fevers without focus in well-vaccinated children are increasingly common situations that the pharmacist has to deal with.

All this means that, in order to provide the best possible care, the pharmacist must continuously update themselves, even if they are not a specialist, since the percentage of visits or inter-consultations related to infection is very high. If we add to this the increasing amount of information provided by parents, sometimes not always contrasted, professional updating becomes essential to be able to provide adequate information according to the current scientific evidence at all times.

With this program you will have the opportunity to study a teaching program that brings together the most advanced and in-depth knowledge in the field, where a group of professors of high scientific rigor and extensive international experience provides you with the most complete and up-to-date information on the latest advances and techniques for risk situations, prevention measures and therapy  in Infectious diseases.

This Postgraduate diploma in Risk Situations Prevention Measurements and Infectious Diseases Therapy  contains the most complete and up-to-date program on the market”

This Postgraduate diploma in Risk Situations Prevention Measurements and Infectious Diseases Therapy contains the most complete and up-to-date scientific program on the market. The most important features include: 

• Clinical cases presented by experts in the different specialisms
• The graphic, schematic, and practical contents with which they are created provide scientific and practical information on the disciplines that are essential for professional practice
• Developments on Risk Situations, Prevention Measurements and Infectious Diseases Therapy
• An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course
• With special emphasis on evidence-based medicine and research methodologies in Risk Situations, Prevention Measurements and Infectious Diseases
• Therapy
• All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

ThisPostgraduate diploma may be the best investment you can make when selecting a refresher program, for two reasons: in addition to updating your knowledge in Risk Situations Prevention Measurements and Infectious Diseases Therapy, you will obtain a qualification endorsed by TECH Global University"

Forming part of the teaching staff is a group of , professionals in the field of Risk Situations Prevention Measurements and Infectious Diseases Therapy, who bring their work experience to this program, as well as a group of renowned specialists, recognized by esteemed scientific communities.

Thanks to its multimedia content developed with the latest educational technology, it will allow the professional a situated and contextual learning, that is to say, a simulated environment that will provide an immersive learning programmed to prepare for real situations.

This program is designed around Problem-Based Learning, by means of which the pharmacist must try to solve the different situations of professional practice that arise during the course. For this reason, you will be assisted by an innovative, interactive video system created by renowned and experienced experts in the field of Prevention and Therapy in Infectious diseases with extensive teaching experience.

Don’t miss the opportunity to update your knowledge in Risk Situations Prevention Measurements and Infectious Diseases Therapy in order to improve your patient care"

The structure of the contents have been designed by a team of professionals knowledgeable about the implications of specialization in daily Pharmacist practice, aware of the relevance of the current situation  of training to be able to treat pediatric patients in risk situations problems and who are committed to quality teaching through new educational technologies.

Take the step to get up to date on the latest developments in Risk Situations Prevention Measurements and Infectious Diseases Therapy”

Module 1. HIV Infection in Pediatrics and Adolescence 

1.1. Vertical Transmission

1.1.1. Current Situation of Vertical Transmission in our Environment
1.1.2. Prevention and Management

1.2. Infection in Adolescents
1.3. Anti-retrovirals in Pediatrics

1.3.1. Updates
1.3.2. Combinations
1.3.3. Determination of Resistance
1.3.4. Side Effects and Metabolic Alterations

1.4. Pharmacokinetics

1.4.1. Interactions
1.4.2. Level Monitoring

1.5. When and How to Start HAART
1.6. Current Management of HBV and HCV Coinfection

Module 2. Infection in the Patient at Risk 

2.1. Children with Immunomodulatory Treatments in Rheumatology

2.1.1. Management of Patients Undergoing Immunomodulatory Treatments

2.2. Current Empiricism of Infections in Oncology Patients

2.2.1. Adenovirus Infections in HematoOncology
2.2.2. Diagnostic and Therapeutic Approach to Febrile Neutropenia in Cancer Patients
2.2.3. Empirical and Targeted Treatment of Infections in Cancer Patients

2.3. Infections and Current Response to Children with Underlying Pathology

2.3.1. Risk infections in Patients with Hemolytic Anemias (emoglobinopathies and Membranopathies)
2.3.2. Treatment of Severe Neutropenia and Congenital and Functional Asplenia
2.3.3. Infections in Children with Cystic Fibrosis

2.4. Current Approach to Infections in the Transplanted Child

2.4.1. Cytomegalovirus and BK Virus Infections in Transplant Recipients

Module 3. Treatment in Pediatric Infectious Diseases 

3.1. Pharmacokinetics and Pharmacodynamics of Antibacterial Agents in Pediatrics
3.2. Bacterial Resistance and Antibiotherapy

3.2.1. Carbapenem-Resistant Enterobacteriaceae, BLES, MRSA, Vancomycin-Resistant
3.2.2. Resistance to Antifungals

3.3. Choice of Antibiotics in the Different Families

3.3.1. Beta-Lactams
3.3.2. Macrolides
3.3.3. Aminoglycosides
3.3.4. Fluoroquinolones

3.4. Choice Among the Different Families of Antifungals

3.4.1. Azoles
3.4.2. Echinocandins
3.4.3. Polyenes

3.5. Resurrection of Old Therapeutic Agents
3.6. New Antibiotics or Families

3.6.1. Ceftobiprole, Ceftaroline, Doripenem, Dalbavancin, Talavicina, Teixobactin, Ceftolozane-Tazobactam, Ceftazidime-Avibactam, Lugdunin, Oritavancin, Iclaprim, Ramoplanin, Fidaxomicin, Fidaxomicin

3.7. New Tuberculostatics
3.8. Antibiotherapy in Obese Pediatric Patients
3.9. New Requirements for the Rational and Judicious Choice of Suitable Treatment

3.9.1. Antibiotic Policy in Hospitals and Primary Care Optimization Program

3.10. Role of Agriculture and Animal Husbandry in Antibiotic Resistance
3.11. Use of Antivirals

3.11.1. In Immunocompetent Patients
3.11.2. Use of Antivirals in Immunocompromised Patients

3.12. Essential Antiparasitic Drugs in Pediatrics
3.13. Update on Allergy to Anti-Infectives Alternatives
3.14. Monitoring of Anti-Infectives
3.15. Update on the Duration of Antibiotic Treatments

Module 4. Preventive Measures 

4.1. Control and Response to Hospital Outbreaks of Infection

4.1.1. Common Microorganisms
4.1.2. Current Multidrug-Resistant Microorganisms (Including Decontamination in the MRSA Patient)

4.2. Hospital Organization and Control of Today's Multidrug-Resistant Microorganisms
4.3. Current Indications for Isolation in Hospital Pediatrics
4.4. Current Vaccines

4.4.1. Prematurity
4.4.2. Immuno-deficient Child
4.4.3. Child Undergoing Immunosuppressive Treatments
4.4.4. Splenectomized Patients
4.4.5. Transplant Recipients
4.4.6. HIV

4.5. Update on Vaccination of Children in Special Situations
4.6. Current Indications for Antibiotic Prophylaxis
4.7. Indications for Prophylaxis

4.7.1. In case of Accidental Puncture
4.7.2. Indications for Sexual Abuse Prophylaxis

4.8. Post-Exposure Performance

4.8.1. Chickenpox
4.8.2. Measles
4.8.3. In Hepatitis B
4.8.4. In Hepatitis A
4.8.5. Tuberculosis
4.8.6. Tetanus
4.8.7. Rabies

4.9. Current Status of Perioperative Prophylaxis of the Surgical Patient
4.10. Update on Antibiotic Prophylaxis in Transplant Children and Patients Treated for Atypical Hemolytic Uremic Syndrome

Make the most of this opportunity to surround yourself with expert professionals and learn from their work methodology"